UNSPSC 41131708: Factor deficiency test

In this classification a factor deficiency test is a device used to diagnose specific coagulation defects, to monitor certain types of therapy, to detect coagulation inhibitors, and to detect a carrier state (a person carrying both a recessive gene for a coagulation factor deficiency such as hemophilia and the corresponding normal gene) US FDA regulates Factor deficiency test under 21 CFR 864.7290and under FDA product code GGP.

UNSPSC 41131708 Factor deficiency test is a Commodity code covering laboratory drug testing services and related diagnostic work purchased by state and local governments. State and local buyers under this code are acquiring urinalysis and drug-screening services for offender supervision, employment pre-screening and fitness-for-duty evaluation, and specialized psychiatric medication monitoring. The work encompasses immunoassay screening with confirmatory testing (LC/MS/MS, GC/MS, or other methodology), alternative specimen collection methods (oral fluid and hair testing), and provision of collection staffing and supplies. Testing services operate across multiple specimen types and panel configurations; buyers specify drug panels, confirmation protocols, reporting timelines, and lab certifications required (CLIA, SAMHSA, state licensing, or accreditation bodies such as CAP or ANAB). Issuing bodies include county supervision departments, county human resources and procurement offices, city college systems, and state departments. Counties and cities are the primary repeat purchasers, with Collin County (Texas), Seminole County (Florida), Benton County (Oregon), Pinellas County (Florida), Collier County (Florida), and Clay County (Florida) all soliciting testing services in recent months.

Recent opportunities show concentrated activity in Texas and Florida, with secondary presence in Oregon. Collin County Community Supervision and Corrections Department issued RFP 2026-327 for offender specimen collection and drug testing with 25,031 annual tests, estimated value $600,000, proposals due July 23, 2026. Benton County, Oregon issued RFP SC0200300017156 for urinalysis testing supporting the Family Treatment Court Program with twice-weekly minimum testing, proposals due July 7, 2026. Clay County, Florida issued IFB 25-26054 for physicals and drug testing for non-union and public safety personnel with sixteen line items and per-unit pricing, bids due February 26, 2026. City Colleges of Chicago issued RFP MWJ2603 for employment screening services including pre-employment drug testing and fitness-for-duty services for 1,500 to 1,600 candidates annually, with 25% MBE and 7% WBE participation goals and proposals due March 30, 2026. Collier County, Florida issued RFP 25-8407 for medical director services and drug testing for approximately 2,100 county employees, proposals due August 28, 2025. The code also captures references to drug standards and assay kits for forensic analysis; Pinellas County solicited certified drug reference materials through ITQ 26-0305-ITQ with delivery by June 1, 2026, and the State of Oregon issued a sole source procurement for MyCare Psychiatry Clozapine Assay kits from Saladax Biomedical in May 2026. Nevada Department of Public Safety solicited Intoxilyzer 9000 breath alcohol testing devices in two separate bids (65DPSS3654 and 65DPSS3655, February 2026), though these represent equipment rather than testing services.